Fusion with a fertilizing spermatozoon induces the mammalian oocyte to undergo a remarkable series of oscillations in cytosolic Ca 2+ , leading to oocyte activation and development of the embryo. The exact molecular mechanism for generating Ca 2+ oscillations has not been established. A sperm-specific zeta isoform of phospholipase C (PLCζ) has been identified in mice. Mouse PLCζ triggers Ca 2+ oscillations in mouse oocytes and exhibits properties synonymous with the 'sperm factor' that has been proposed to diffuse into the oocyte after gamete fusion. The present study isolated the PLCζ homologue from human and cynomolgus monkey testes. Comparison with mouse and monkey PLCζ protein sequences indicates a shorter X-Y linker region in human PLCζ and predicts a distinctly different isoelectric point. Microinjection of complementary RNA for both human and cynomolgus monkey PLCζ elicits Ca 2+ oscillations in mouse oocytes equivalent to those seen during fertilization in mice. Moreover, human PLCζ elicits mouse egg activation and early embryonic development up to the blastocyst stage, and exhibits greater potency than PLCζ from monkeys and mice. These results are consistent with the proposal that sperm PLCζ is the molecular trigger for egg activation during fertilization and that the role and activity of PLCζ is highly conserved across mammalian species.
Introduction
The earliest detected signalling event during mammalian oocyte activation by spermatozoa is the release of Ca 2+ from intracellular stores (Stricker, 1999; Runft et al., 2002) . In fertilized mammalian oocytes, this Ca 2+ release occurs shortly after sperm-oocyte membrane fusion and is manifested as a striking series of cytosolic Ca 2+ oscillations (Miyazaki et al., 1993; Swann, 1996; Stricker, 1999) . The oscillations in cytosolic free Ca 2+ are regular, continue for several hours, and cease around the time of formation of the pronuclei (Carroll, 2001) . Ca 2+ oscillations are essential for stimulating embryo development, as their inhibition with N,N'-(1,2-ethanediylbis(oxy-2,1-phenylene))bis(N-(carboxymethyl))-glycine (BAPTA) blocks oocyte activation (Kline and Kline, 1992) and the premature termination of Ca 2+ oscillations prevents the formation of pronuclei (Lawrence et al., 1998) .
The explicit mechanism underlying fertilization-induced Ca 2+ oscillations remains to be fully defined, but is believed to involve activation of the phosphoinositide pathway leading to increased production of inositol 1,4,5-trisphosphate (InsP 3 ) (Stricker, 1999; Runft et al., 2002) . There are three distinct hypotheses to explain the Ca 2+ release observed at fertilization: the 'conduit ', 'contact' and 'content' models (Jaffe, 1991) . The 'conduit' model proposes that sperm-oocyte fusion leads to increased influx of Ca 2+ into the oocyte, leading indirectly to Ca 2+ release (Jaffe, 1991) . This model appears unlikely in mammalian oocytes, as increased Ca 2+ influx alone is not effective in triggering Ca 2+ oscillations (Swann, 1996) , and sperm-oocyte fusion causes Ca 2+ release in the absence of extracellular Ca 2+ (Jones et al., 1998a) . The 'contact' model proposes that a receptor on the oocyte surface couples to either a G-protein or a tyrosine kinase and, upon sperm binding, this receptor activates an oocyte phospholipase Cβ (PLCβ) or PLCγ, respectively, resulting in an increase in intracellular InsP 3 (Runft et al., 2002) . However, this hypothesis seems unlikely in mouse oocytes, as antibodies to Gq proteins fail to block fertilization-induced Ca 2+ release (Williams et al., 1998) . The PLCγ pathway has been proposed on the basis that SH2 protein constructs are able to block Ca 2+ release at fertilization in invertebrate oocytes (Carroll et al., 1997; Shearer et al., 1999) . However, this inhibition does not occur in frog or mouse eggs and oocytes (Mehlmann et al., 1998; Runft et al., 1999) . In addition, in mammals, there is no direct evidence of a sperm-specific plasma membrane receptor capable of stimulating the InsP 3 production pathway.
An alternative hypothesis is that the spermatozoon itself contains a soluble factor that, upon sperm-oocyte fusion, diffuses into the oocyte cytosol and stimulates the InsP 3 pathway (Swann, 1990; Fissore et al., 1998; Stricker, 1999) . Evidence for this hypothesis in mammals comes from the finding that microinjecting protein-based sperm extracts into oocytes from a number of mammalian species elicits Ca 2+ oscillations similar to those seen at fertilization (Swann, 1990; Homa and Swann, 1994; Wu et al., 1997; Tang et al., 2000) . The microinjection of mRNA from spermatogenic cells also triggers Ca 2+ oscillations in mouse oocytes (Parrington et al., 2000) and the introduction of whole spermatozoa into mammalian oocytes (intracytoplasmic sperm injection, ICSI), which avoids any surface contact between the oocyte and spermatozoon, also elicits a similar set of Ca 2+ oscillations (Tesarik et al., 1994; Nakano et al., 1997) . The Ca 2+ -releasing sperm factor appears to be a sperm-specific protein, as extracts from other tissues do not elicit Ca 2+ increases when injected into oocytes (Swann, 1990; Wu et al., 1997) . However, this mechanism is not species-specific, because sperm extracts from hamsters, humans, pigs, cows, frogs and chickens can each trigger Ca 2+ oscillations in mouse oocytes (Homa and Swann, 1994; Wu et al., 1997 Wu et al., , 1998 Tang et al., 2000) .
Previous candidates for the Ca 2+ -releasing sperm factor have been a 33 kDa glucosamine-6-phosphate deaminase (Parrington et al., 1996) and a truncated form of the c-kit transmembrane receptor (tr-kit) (Sette et al., 1997) . However, both these candidates now seem unlikely to be the sperm factor (Wolosker et al., 1998; Parrington et al., 1999) . More recent studies have suggested that the sperm factor itself may have a PLC activity (Jones et al., 1998b; Rice et al., 2000) . However, all of the established somatic PLC isozymes tested have failed to elicit Ca 2+ oscillations in oocytes at concentrations that approximate the PLC activity of sperm extracts (Jones et al., 2000; Parrington et al., 2002; Runft et al., 2002) . The known somatic PLC isozymes also fail to correlate with the Ca 2+ -releasing activity of sperm extracts that have been chromatographically fractionated (Wu et al., 2001; Parrington et al., 2002) .
A novel, sperm-specific isoform of PLC, named PLCζ, has been identified, and immunodepletion was used to attribute the Ca 2+ -releasing activity of mouse and hamster sperm extracts to the presence of PLCζ (Saunders et al., 2002) . Microinjection of complementary RNA (cRNA) of the mouse PLCζ (mPLCζ) triggered Ca 2+ oscillations similar to those observed at fertilization in mouse oocytes, and evoked early embryonic development to the blastocyst stage (Saunders et al., 2002) . These data indicate that PLCζ correlates with the 'sperm factor' in mice. In the present study, human and simian PLCζ (hPLCζ and sPLCζ, respectively) were identified, together with the genomic organization and tissue expression profile of human PLCζ. Human and simian PLCζ are both effective at inducing Ca 2+ oscillations in mouse oocytes, and human PLCζ can also trigger development to blastocyst. Human PLCζ is more potent in causing Ca 2+ oscillations than the mouse and monkey isoforms.
Materials and Methods

Molecular cloning and sequence analysis of human PLCζ
Blast searches of the human expressed sequence tag (EST) database (www.ncbi.nlm.nih.gov/BLAST) using known mammalian PLC sequences revealed several, closely related, novel sequences of 408-559 bp with distinct homology to the delta class of phosphoinositide-specific PLCs, and all sequences were derived from testis (accession numbers AA861064, AA398866, AA609626, AA620685 and AA435866). The full sequence of a putative PLC expressed by the testis was derived by two-step, nested PCR amplification using an adult human testes large insert cDNA library (500 ng) in the lambda TriplEx2 vector (HL5503u; Clontech, Oxford). The oligonucleotide primers were derived from conserved regions of the ESTs, and primers were designed against the library vector adapter sequence. PCR amplification was carried out with Taq DNA polymerase using conditions of 32 cycles, and temperatures of 94ЊC (1 min), 70ЊC (45 s) and 72ЊC (3 min). The testis library template-specific, amplified DNA products were cloned into pCR-BluntII-TOPO (Invitrogen, Paisley); the nucleotide sequence was determined (Prism Big Dye kit; Applied Biosystems International, Warrington) and then analysed for open reading frame (ORF) using MacVector 6.5 (Oxford Molecular, Oxford). Oligonucleotide primers were designed to incorporate the putative start and stop codons of a novel, testis-derived PLC sequence. The full-length PLC was amplified using Pfu polymerase, using 32 cycles of 94ЊC (1 min), 62ЊC (1 min) and 72ЊC (3 min). The single, amplified approximately 1.9 kb band was cloned into pCR-XL-TOPO and the insert DNA sequenced along both strands as described above. The 1.9 kb insert was subcloned into pTarget (Promega, Southampton) to generate pTarget-hPLCζ. Homology sequence analysis and alignment with related PLCs was performed using ClustalW (www.clustalw.genome.ad.jp) and domain structure by RPS-Blast (www.ncbi.nlm.nih.gov/structure/cdd). The Genbank accession number for human PLCζ is AF532185.
Identification and cloning of simian PLCζ
A cynomolgus monkey cDNA library was prepared from size-selected, adult Macaca fascicularis testis cDNAs of > 1.5 kb, and several novel, full-length insert DNA sequences were determined. Blast searching with the hPLCζ sequence revealed two homologous simian sequences derived from the adult M. fascicularis testis cDNA library (accession numbers AB070108 and AB070109). The ORF within these two cynomolgus monkey cDNA clones were amplified by PCR with Pfu DNA polymerase as described above, cloned into pcDNA3.1-V5-His-TOPO (Invitrogen) (pcDNA-sζ) and the insert DNA sequenced along both strands, as described above. Homology sequence analysis and alignment was performed using ClustalW (www. clustalw.genome.ad.jp) and domain structure by RPS-Blast (www.ncbi.nlm.nih.gov/structure/cdd).
Northern and western blot analysis
A 950 bp fragment from the 3Ј terminal of the hPLCζ ORF was amplified by PCR with Pfu DNA polymerase as described above, and cloned into pCR-BluntII-TOPO. Antisense cRNA, labelled with digoxygenin, was synthesized from the linearized plasmid (DIG Nucleic Acid labelling system; Roche Molecular Biochemicals, Lewes) and used as a riboprobe for hybridization analysis with a human male tissue RNA blot (Origene, Rockville, MD), containing equal loading of 20 µg total RNA (2 µg) -1 polyA + mRNA per lane, and standardized with an actin probe. The hybridized probe was detected using a DIG luminescence detection kit (Roche Molecular Biochemicals). For Western blot analysis, rabbit antisera was raised to a keyhole limpet haemocyanin (KLH)-conjugated 19mer peptide sequence, GYRRIPLFSRMGESLEPAS, corresponding to an amino acid sequence located near to the carboxy-terminal end of the putative human PLCζ sequence. Human sperm extracts (Parrington et al., 1999) were added to SDS sample buffer and proteins separated by 10% polyacrylamide gel electrophoresis, transferred to PVDF membrane, and probed with rabbit anti-hPLCζ peptide antisera (Saunders et al., 2002) .
Complementary RNA synthesis and in vitro translation
Complementary RNA (cRNA) encoding the complete ORF of human and monkey PLCζ was produced from the linearized hPLCζ and sPLCζ plasmid constructs described above, using a Ribomax RNA synthesis kit (Promega), in the presence of 3 mmol m7G(5Ј)ppp(5Ј)G l -1 (37ЊC, 2 h). Synthesized cRNA products were analysed by electrophoresis (1% native agarose gel, 50% formaldehydeformamide in loading buffer), isopropanol precipitated, and resuspended in DEPC-treated water containing 4U RNasin µl -1 (Promega). Complementary RNAs were assayed by in vitro expression of PLCζ protein (Reticulocyte Lysate System, Promega) in the presence of [ 35 S]methionine, and analysed by 10% SDS-PAGE and autoradiography, as described by Saunders et al. (2002) .
Preparation and handling of gametes
Experiments were carried out on mouse oocytes in either Hepes-buffered KSOM (H-KSOM) or amino acid supplemented KSOM (Summers et al., 2000) . All compounds were from Sigma, unless stated otherwise. Female MF1 mice were superovulated by an injection of 5 iu eCG (PMSG; Intervet, Milton Keynes) and injection with hCG (Intervet) 48 h later. Oocytes were collected after a further 13.5-14.5 h, as described by Lawrence et al. (1998) and maintained in 100 µl droplets of H-KSOM under mineral oil at 37ЊC. The cRNA injections were carried out between 14.5 and 15.5 h after hCG injection. Activation of oocytes for development studies was carried out in H-KSOM containing 2 µmol cytochalasin D l -1 for 4 h, to prevent second polar body extrusion. Further development to two-cell and blastocyst stages was carried out in 50 µl droplets of KSOM under mineral oil at 37ЊC in a 5% CO 2 incubator.
Measurement of intracellular Ca 2+ and microinjection
Intracellular calcium changes were measured with Fura red-AM (Molecular Probes, Eugene, OR). Stock solutions of 1 mmol l -1 dissolved in DMSO plus 5% (w/v) pluronic F127 (Molecular Probes) were used to load the oocytes, with a final concentration of 4 µmol Fura red-AM l -1 for 10 min. The loading medium was also supplemented with sulfinpyrazone, which helps to prevent compartmentalization and extrusion of the dye (Lawrence et al., 1998) . Ca 2+ measurements were carried out on charge coupled devicebased imaging systems using a Nikon Diaphot with epifluorescence controlled by Newcastle Photometrics Multipoint System, Newcastle-upon-Tyne, as described by Lawrence et al. (1998) , or a Zeiss Axiovert 100 with illumination from a monochromator (Photonics, Robertsbridge) controlled by MetaFluor v4.0 (Universal Imaging Corp, Marlow). After loading with Fura red-AM, oocytes were washed in H-KSOM and placed on the stage of a Nikon Diaphot. Oocytes were microinjected as described by Swann (1990) . The cRNA solutions were diluted with an injection buffer (120 mmol KCl l -1 ; 20 mmol Hepes l -1 , pH 7.4). The volume injected was estimated from the diameter of cytoplasmic displacement caused by the bolus injection. All injections were 3-5% of the oocyte volume.
Results
Identification and characterization of a novel human PLCζ sequence
Previous studies showed that various somatic PLC isoforms were ineffective at triggering Ca 2+ oscillations in eggs, indicating that a putative sperm-specific PLC isoform remains to be identified (see Introduction). In early 1999, a Blast search of the human EST database for uncharacterized PLC-like sequences identified a group of novel, related sequences, specifically derived from testis, displaying homology to the δ isoforms of PLC. The full-length sequence of this PLC was obtained by rapid amplification of cDNA ends (RACE)-PCR from a human testis cDNA library, using oligonucleotide primers designed to the human ESTs and flanking lambda vector sequence. Nucleotide sequence analysis of the 2.2 kb full-length cDNA revealed a single ORF of 1824 bp, flanked by 5Ј and 3Ј untranslated regions of approximately 200 and 120 bp, respectively. The ORF encodes a protein of 608 amino acids (Fig. 1 deduced molecular mass of 70 kDa and a predicted isoelectric point of 9.2. The molecular mass of the human protein is similar to that of mouse PLCζ (74 kDa; Saunders et al., 2002) but smaller than any previously characterized mammalian PLCβ,γ,δ,ε isoforms (85-230 kDa).
ClustalW sequence alignment of the human protein with mouse PLCζ showed a striking sequence identity, confirming it as the human homologue of PLCζ (hPLCζ; Fig. 1) . Similarly, the M. fascicularis testis sequences of 641 and 640 amino acids (accession numbers AB070108 and AB070109, respectively), both with deduced molecular mass of 74 kDa, also aligned optimally with human and mouse PLCζ and were thus identified as simian PLCζ homologues (sPLCζ; Fig. 1 ). The only difference between the two simian sequences was that EEEEKF in residues 334-339 of AB070108 corresponded to EEE-RF in AB070109. Unless stated otherwise, further reference to studies with simian PLCζ sequences in this report implies the 641 residue form, AB070108, as no other functionally significant differences have been observed with the 640 residue, AB070109.
Comparison of the PLCζ sequences from the three species revealed a higher percentage identity between the primate sequences, hPLCζ and sPLCζ (90%), than between the primate and the rodent sequences, mPLCζ (70 and 71% for comparison between the mouse and the human and simian sequences, respectively; Fig. 2a ). Identity of all three PLCζs with PLCδ1 was 33%. As originally observed for mouse PLCζ (Saunders et al., 2002) , the multiple sequence alignment with PLCδ1 ( Fig. 1) demonstrates that all the PLCζs lack a plextrin-homology (PH) domain at the N-terminus, a domain found in most other animal PLCs (Fig.  2b) . The other conserved PLC domains (the EF-hand region, the X and Y catalytic domains, and the C2 domain) were present in the human, simian and mouse PLCζ sequences (Fig. 2b) . The shorter length of the human compared with mouse and simian PLCζ sequences (608 versus 647 and 641, respectively) is due to a smaller X-Y linker segment, the region located between the X and Y catalytic domains (Figs 1 and 2b) . A summary of the molecular properties of mouse, human and simian PLCζs is presented (Table 1) . A Blast search of the public domain human genome database identified a sequence of 179 456 bp, assembled in two ordered pieces (accession number AC023940) and containing the entire human PLCζ cDNA sequence. The genomic organization of the human plc-zeta gene (Fig. 3 Table 2 ). located on the short arm of chromosome 12 (12p12.3). The ATG initiation methionine codon is located in exon 2 and the TAA stop codon in exon 15 (Fig. 3, Table 2 ). A short intron sequence of 123 bp occurs between exons 8 and 9 and is in-frame, indicating that it may form the central part of a single larger exon that incorporates both exons 8 and 9. In accord with this suggestion, the in-frame translation of the 123 bp sequence yields a sequence of 41 residues that is homologous to the corresponding segment within the X-Y linker sequence in M. fascicularis PLCζ (73% identity, Fig. 4 ). This finding raises the possibility that alternative splicing of this region occurs to produce multiple forms of hPLCζ. An attempt was made to demonstrate specifically the presence of this 123 bp sequence in the human cDNA library, which was derived from testes pooled from 25 unrelated males, aged 25-64. However, using PCR primers immediately flanking the X-Y linker region of hPLCζ, no evidence was found for expression of this 123 bp sequence in the testis cDNA library (data not shown). In addition, the distinctive lack of a PH domain in the three PLCζ sequences identified so far (Fig. 2b) was consistent with the inability to identify any sequence homology to the PLCδ1 PH domain within the 179 kb human genomic contig containing the 15 exons of the plc gene (data not shown). Northern blot analysis using a digoxygenin-labelled, anti-sense cRNA probe derived from the 3Ј-end of hPLCζ displayed specific hybridization only to a 2.2 kb mRNA expressed in relative abundance in human testis (Fig. 5a ). This finding is consistent with the 2.2 kb cDNA obtained by full-length RACE-PCR (Fig. 1) . No other band was detected in any of the other 11 human tissues, which was a similar result to that obtained in the hybridization analysis of mouse tissues with mPLCζ that identified a testis-specific 2.3 kb transcript (Saunders et al., 2002) . The expression in human spermatozoa of a protein corresponding to hPLCζ was confirmed by immunoblot analysis of human sperm extracts. Antisera raised to a peptide sequence deduced from the hPLCζ of 608 residues recognized a single protein band of approximately 70 kDa in human spermatozoa (Fig.  5b ), in congruence with the 70 kDa protein predicted from the 1824 bp ORF (Fig. 1, Table 1 ).
Triggering of Ca 2+ oscillations in mouse oocytes by human PLCζ
Microinjection of mouse PLCζ cRNA into mouse oocytes triggers Ca 2+ oscillations indistinguishable from those associated with fertilization (Saunders et al., 2002) . The ability of hPLCζ to cause Ca 2+ changes was examined by microinjecting cRNA encoding hPLCζ into MII-arrested mouse oocytes at a pipette concentration of 20 µg hPLCζ cRNA ml -1 , which corresponds to 0.001 mg ml -1 in the oocyte after a 3-5% injection volume. A representative Ca 2+ recording for each of the four different concentrations of hPLCζ cRNA that were microinjected is shown ( Fig.  6a-d) . At a concentration of 20 µg ml -1 , hPLCζ cRNA triggered high frequency Ca 2+ oscillations within 10-15 min of microinjection (mean interspike interval: 4.21 Ϯ 1.79 min). As was observed with mouse PLCζ cRNA and hamster sperm extract microinjection, Ca 2+ oscillations of lower frequency were obtained with lower concentrations of stimulus (Swann, 1990; Saunders et al., 2002) . Even at pipette concentrations of 0.02 µg ml -1 , hPLCζ cRNA could induce Ca 2+ oscillations within 2 h of microinjection.
Although a wide range of cRNA concentrations (20 to 0.02 µg ml -1 ) were used, the Ca 2+ oscillations observed at each concentration lasted for a similar period of 3-4 h ( Fig. 6a-d) . The mean interspike interval data showing the dose-response relationship with hPLCζ cRNA is summarized (Fig. 6e ).
Embryo development with hPLCζ
Microinjection of 20 µg mPLCζ ml -1 into mouse oocytes induces Ca 2+ oscillations and development to the blastocyst stage at rates comparable to that observed in in vitro fertilization (Saunders et al., 2002) . Oocytes arrested at metaphase II were injected with 20, 2.0 and 0.2 µg ml -1 hPLCζ cRNA and monitored after 24 and 96 h to examine whether hPLCζ is also able to support development, and what effect the oscillation frequency has on embryo development. All three concentrations were effective at activating the oocytes and enabling development to the two-cell stage (Fig. 7) . Mouse embryo development to morula-blastocyst was 33.3 and 38.9% after injection with 2.0 and 0.2 µg ml -1 hPLCζ cRNA, respectively (Fig. 7a) . These results are comparable to developmental rates observed in in vivo fertilization and parthenogenetic activation of 55-60% under the conditions described and using outbred mouse strains (Saunders et al., 2002) . However, the high Ca 2+ oscillation frequency (low mean interspike interval) produced with 20 µg hPLCζ ml -1 was ineffective at supporting development to the morula-blastocyst stage (1.8% of oocytes reached the morula-blastocyst stage) and most embryos arrested at the two-cell stage.
Mouse embryos produced by microinjection of hPLCζ cRNA are similar in morphology to those obtained after in vivo fertilization (Fig. 7b,c) , although the number of blastocyst cells was not determined. These data indicate that microinjection of hPLCζ cRNA into unfertilized eggs alone can trigger early embryonic development to the blastocyst stage in mouse embryos, but it appears that the high frequency of Ca 2+ oscillations caused by higher doses of hPLCζ is detrimental to development beyond the two-cell stage.
Triggering of Ca 2+ oscillations in mouse oocytes by simian PLCζ
The observations described above (Figs 6 and 7) and in a previous report (Saunders et al., 2002) show that the human and mouse PLCζ can cause fertilization-like Ca 2+ oscillations that initiate activation and development of mouse oocytes. The identification of two related, testis-specific cDNA sequences of 2.3 kb from M. fascicularis (Fig. 1) , and the high degree of similarity of their ORF with the human and mouse PLCζ (Fig. 2) , enabled the prediction that these sequences were simian PLCζ homologues. Therefore, the ability of cRNA prepared from the two forms of sPLCζ, designated s 1 PLCζ and s 2 PLCζ (AB070108 and AB070109, respectively) to generate Ca 2+ oscillations in mouse oocytes (e) Mean interspike interval of Ca 2+ oscillations in mouse oocytes triggered by the various hPLCζ cRNA concentrations. The number of microinjected oocytes is shown above each dose. The mean interspike interval differs significantly among doses (Student's unpaired t test; P < 0.0001) (20 µg ml -1 : 4.21 Ϯ 1.79; 2.0 µg ml -1 : 9.26 Ϯ 7.14; 0.2 µg ml -1 : 16.0 Ϯ 6.40; 0.02 µg ml -1 : 24.34 Ϯ 7.68). was compared. Both forms of sPLCζ were able to trigger Ca 2+ oscillations and no functional difference was detected upon microinjecting either s 1 PLCζ or s 2 PLCζ cRNA (data not shown). Therefore, s 1 PLCζ (AB070108) was used for all subsequent experiments. s 1 PLCζ cRNA triggered dosedependent Ca 2+ oscillations in mouse oocytes comparable to those seen with human and mouse PLCζ, at each of the three doses tested (0.2, 0.02, 0.002 mg ml -1 ) (Fig. 8a-c) . Similar to the results obtained with human PLCζ (Fig. 6a-d) , the period over which Ca 2+ oscillations occurred was 3-4 h for each of the three s 1 PLCζ cRNA concentrations microinjected. However, the frequency of Ca 2+ spikes was different for each cRNA concentration, with the mean interspike interval decreasing with increasing concentration of stimulus (Fig. 8d) . These data indicate that PLCζ, derived from the spermatozoa or testis of various mammals lacks species specificity and, once introduced by microinjection, is able to trigger Ca 2+ oscillations in heterologous mammalian oocytes. This finding is fully consistent with earlier observations that sperm extracts derived from various sources, including non-mammalian species, each caused Ca 2+ oscillations in different mammalian oocytes (Homa and Swann, 1994; Wu et al., 1997; Tang et al., 2000) .
Mean interspike intervals for the three different mammalian forms of PLCζ at various pipette concentrations of cRNA were compared (Fig. 9 ). Microinjecting cRNA for mPLCζ, hPLCζ or sPLCζ all produced Ca 2+ oscillations over a range of concentrations from 200 to 2 µg ml -1 . However, hPLCζ was distinct in its ability to cause Ca 2+ oscillations at the lower concentrations of 0.2-0.02 µg ml -1 ( Fig. 9 ), indicating that, under the same experimental conditions, the human form of PLCζ is more effective at generating Ca 2+ oscillations in mouse oocytes than is the PLCζ from mice and monkeys.
Discussion
There is mounting evidence that during fertilization, the spermatozoon delivers a cytosolic factor that diffuses into the ooplasm after gamete fusion and triggers the Ca 2+ changes required for embryo development (Stricker, 1999; Swann et al., 2001) . The Ca 2+ -releasing activity of a cytosolic sperm factor has been demonstrated in several mammalian species. In particular, microinjection of human sperm extracts is able to cause Ca 2+ oscillations in both human and mouse oocytes (Homa and Swann, 1994; Palermo et al., 1997) . The ICSI technique can also lead to generation of the crucial Ca 2+ oscillations that precede activation of the oocyte (Nakano et al., 1997) . As has been observed with sperm extract microinjection, the species of mammalian spermatozoa used for ICSI does not need to match the species of the oocyte, since ICSI with either human or monkey spermatozoa can activate mouse oocytes (Rybouchkin et al., 1996; Ogonuki et al., 2001) . These reports indicate that the cytosolic sperm factor, when identified, would be present in humans and monkeys, and would be able to act across species. A novel, sperm-specific enzyme, PLCζ, has been identi- fied as being synonymous with the mouse sperm factor responsible for the Ca 2+ -releasing activity of sperm extracts (Saunders et al., 2002) . The presence of a PLCζ-like immunoreactive protein in hamster and boar sperm extracts has also been demonstrated (Saunders et al., 2002) . However, to the authors' knowledge, no other PLCζs have been cloned and functionally characterized in species other than the mouse.
In the present study, the full-length sequences for both the human and simian PLCζ were identified, the organizational structure of the human plcζ gene was described and the reduced length of the X-Y linker sequence in the human PLCζ was noted. Analysis of human tissues showed that hPLCζ is expressed solely in testis tissue and is readily detected in human sperm extracts. The PLCζ from humans and cynomolgus monkeys, like the PLCζ of mice, lacks the amino-terminal PH domain found in other vertebrate somatic PLCs (Katan, 1998; Rebecchi and Pentyala, 2000; Saunders et al., 2002) . Because the human and simian PLCζs also possess the ability to trigger Ca 2+ oscillations in oocytes, the lack of a PH domain appears to be an important feature of PLCζ. Hence, the distinctive domain structure of the sperm PLCζ is likely to be critical for the unique Ca 2+signalling properties exhibited by this isoform during fertilization (Saunders et al., 2002) . Furthermore, the high degree of conservation of the three identified PLCζ protein sequences and their uniform Ca 2+ -mobilizing effects in oocytes are consistent with the conserved action of sperm extracts from a range of species in triggering Ca 2+ oscillations in oocytes from various mammals.
In addition to demonstrating that hPLCζ and sPLCζ are able to cause Ca 2+ oscillations in mouse oocytes, empirical evidence was obtained that hPLCζ is more effective in causing Ca 2+ oscillations than are sPLCζ or mPLCζ. The minimal amount of hPLCζ cRNA required to trigger Ca 2+ oscillations was one to two orders of magnitude lower (0.2-0.02 µg ml -1 ) than the minimally effective dose of mouse or simian PLCζ cRNA (2 µg ml -1 ). These differences were observed as a consistent feature with different batches of cRNA that were each tested for expression in vitro (data not shown). Therefore, the superior potency of hPLCζ cRNA is likely to represent a genuine feature of the hPLCζ protein. This contention is supported indirectly by the linear correlation between amount of cRNA injected and protein expression observed in mouse oocytes with mPLCζ (Saunders et al., 2002) . Thus, it could be predicted that there would be at least an order of magnitude difference between the sensitivity of mouse oocytes to hPLCζ and their sensitivity to mPLCζ. It is not clear why hPLCζ exhibits greater effectiveness than mPLCζ or sPLCζ. One distinct structural difference in hPLCζ compared with mPLCζ or sPLCζ that might be related to the higher potency is the shorter X-Y linker sequence of hPLCζ, which reduces the number of acidic residues and results in a basic pI value of 9.3. It is possible that the sperm factor may need to be more vigorous in some species than in others. For example, dilution of the sperm factor is greater in humans, as the volume of the human oocyte is several times that of a mouse oocyte. Intrinsic differences in the sperm factor sensitivity of oocytes from different species may also be important as, for example, mouse oocytes are more sensitive to sperm factor-induced Ca 2+ release than are oocytes from some other species, such as hamsters (Parrington et al., 1996) . In addition, different amounts of PLCζ may be present in the spermatozoa from individual species, and there may be a relationship between oocyte sensitivity and concentration of sperm PLCζ.
Subsequent to stimulating Ca 2+ oscillations in mouse oocytes, human PLCζ was also able to trigger development of embryos to the blastocyst stage. This finding indicates that hPLCζ is able to produce all of the normal events of oocyte activation. However, one feature of the greater efficacy of hPLCζ is that high cRNA concentrations caused very high frequency Ca 2+ oscillations in mouse oocytes. At concentrations of cRNA that resulted in Ca 2+ oscillations of approximately one spike every 5 min, hPLCζ was able to effect oocyte activation, but the embryos arrested at the two-cell stage. High frequency Ca 2+ oscillations may lead either to apoptosis of oocytes or to developmental changes in post-implantation embryos (Gordo et al., 2000; Ozil and Huneau, 2001) . The present data provide the first indication that high frequency Ca 2+ oscillations can also activate an oocyte, but this non-physiological stimulus leads to arrest during the early cleavage stages. The molecular mechanism causing this developmental block remains to be determined; however, it is possible that embryos arrest at the two-cell stage in these experiments as a result of failure of zygotic genome activation. The present data indicate that both the molecular properties and quantity of sperm PLCζ introduced into an oocyte at fertilization are critical for successful embryonic development.
The discovery and characterization of PLCζ from different species as an effective trigger for Ca 2+ release and subsequent activation of mammalian oocytes will enable developmental biologists to study the mechanisms of early development using the physiological activating factors. Although the present experiments crossed species in studying the effect of human and monkey isoforms of PLCζ in mouse oocytes, hPLCζ and sPLCζ would be expected to be similarly effective in stimulating Ca 2+ oscillations in human and monkey oocytes, as has been reported at fertilization in these two species (Taylor et al., 1993; Wu et al., 1996) . Identification of the human sperm PLCζ and corresponding plcζ gene structure enables detection, and possibly treatment, of male infertility resulting from a PLCζ defect, in which otherwise normal spermatozoa would be predicted to be unable to activate the oocyte (Rybouchkin et al., 1996; Battaglia et al., 1997; Palermo et al., 1997) . Availability of hPLCζ may also be pivotal to increasing oocyte activation rates in IVF, ICSI and nuclear transfer techniques in the treatment of human disease. This work was supported by a SIF grant to F. A. Lai from the University of Wales College of Medicine. K. Swann holds a Wellcome Trust grant.
